Enunciado

There is no evidence that hydroxychloroquine helps
Covid-19 patients. So why is Congress still discussing it?

By Ashish Jha
Dean of the Brown University School of Public Health
Nov 24, 2020

Last week, in the United States Senate, the conversation was
all about the drug hydroxychloroquine. There has been no
evidence that hydroxychloroquine improves outcomes for
Covid-19 patients; some studies have found that it causes
more harm than good. The hearing and the theater around it
reflect the disinformation campaigns that have undermined
belief in science. Neither Ron Johnson, the Wisconsin senator
who is the chairman of the committee, nor his chosen
witnesses showed more than a passing interest in evidence.
Intuition and the personal experiences of individual doctors
were the guiding principles. Early in the pandemic, President
Trump referred to hydroxychloroquine as a “game changer”; “I
feel good about it”, he said.
That’s not how we practice medicine. We have to protect lives
through public health measures while we await widespread
vaccinations. By endorsing unfounded therapies, we risk
jeopardizing a century’s work of medical progress. Do we
really want to go back to not using the best evidence to decide
which treatments work? Do we want to let politicians prescribe
our medications? Science and evidence are the tools we use
to know what is true. They are the foundation of modern
medicine and public health.
(Adaptado de https://www.nytimes.com/2020/11/24/opinion/hydroxychloro
quine-covid.html. Acessado em 06/06/2021.)

Com base no texto, assinale a alternativa que responde à
pergunta apresentada no título do artigo.